Castle Biosciences, Inc. will present new data on its gene expression profile risk-stratification test for patients with cutaneous squamous cell carcinoma , DecisionDx®-SCC, and its GEP.
Castle Biosciences Inc (CSTL) to Present New DecisionDx-SCC and DecisionDx-Melanoma Data streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BioSyent Pharma to Introduce Gelclair® at AHNS 11th International Conference on Head and Neck Cancer itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, will present new data on its gene expression profile risk-stratification test for patients.